Yu Deng
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Rehabilitation top 5%
- Wound Healing and Treatments
Papers in
- Oncology 11
- Cancer-related Molecular Pathways 5
- Cancer Immunotherapy and Biomarkers 2
-
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Jerry H. Wang (3 shared papers)Robert Zhong Qi (2 shared papers)Jin‐Ao Duan (2 shared papers)Djohan Kesuma (2 shared papers)Yongcheng Song (2 shared papers)Fulun Li (15 shared papers)Xiao‐Jing Wang (5 shared papers)Gangwen Han (5 shared papers)
- Journals
- International Immunopharmacology (3 papers)Molecular Carcinogenesis (3 papers)Journal of Chinese Integrative Medicine (2 papers)BMC Complementary Medicine and Therapies (2 papers)Medical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yu Deng
39 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 82
- Cancer Research 250
- Rehabilitation 62
- Molecular Biology 541
- Oncology 128
- Complementary and alternative medicine 42
Countries citing papers authored by Yu Deng
This map shows the geographic impact of Yu Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Deng more than expected).
Fields of papers citing papers by Yu Deng
This network shows the impact of papers produced by Yu Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Deng. The network helps show where Yu Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 165 | |
| 2 | 2010 | 145 | |
| 3 | 2002 | 124 | |
| 4 | 2017 | 87 | |
| 5 | 2013 | 74 | |
| 6 | 2009 | 68 | |
| 7 | 2011 | 60 | |
| 8 | 2003 | 56 | |
| 9 | 2011 | 46 | |
| 10 | 2018 | 39 | |
| 11 | 2018 | 39 | |
| 12 | 2010 | 36 | |
| 13 | 2018 | 34 | |
| 14 | 2013 | 29 | |
| 15 | 2021 | 28 | |
| 16 | 2018 | 25 | |
| 17 | 2022 | 25 | |
| 18 | 2020 | 24 | |
| 19 | 2022 | 24 | |
| 20 | 2018 | 23 |
About Yu Deng
Yu Deng is a scholar working on Oncology, Cancer Research, Molecular Biology, Rehabilitation and Immunology, having authored 40 papers that have together received 1.3k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (5 papers), Cancer-related Molecular Pathways (5 papers), Wound Healing and Treatments (4 papers), Mechanisms of cancer metastasis (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Melanoma and MAPK Pathways (3 papers), Dermatology and Skin Diseases (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Cancer Research (250 citations), Rehabilitation (62 citations), Molecular Biology (541 citations), Oncology (128 citations) and Complementary and alternative medicine (42 citations). Yu Deng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jerry H. Wang, Robert Zhong Qi, Jin‐Ao Duan, Djohan Kesuma, Yongcheng Song, Fulun Li, Xiao‐Jing Wang, Gangwen Han, Hui Deng and Feng Bi. Their work appears in journals such as International Immunopharmacology, Molecular Carcinogenesis, Journal of Chinese Integrative Medicine, BMC Complementary Medicine and Therapies and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.